Related Experiment Video
Updated: May 7, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
EWS and RE1-Silencing Transcription Factor Inhibit Neuronal Phenotype Development and Oncogenic Transformation in
Savita Sankar1, Nicholas C Gomez, Russell Bell
1Department of Oncological Sciences, University of Utah School of Medicine, Salt Lake City, UT, USA.
Abstract:
The gene encoding EWS (EWSR1) is involved in various chromosomal translocations that cause the production of oncoproteins responsible for multiple cancers including Ewing sarcoma, myxoid liposarcoma, soft tissue clear cell sarcoma, and desmoplastic small round cell sarcoma. It is well known that EWS fuses to FLI to create EWS/FLI, which is the abnormal transcription factor that drives tumor development in Ewing sarcoma. However, the role of wild-type EWS in Ewing sarcoma pathogenesis remains unclear. In the current study, we identified EWS-regulated genes and cellular processes through RNA interference combined with RNA sequencing and functional annotation analyses. Interestingly, we found that EWS and EWS/FLI co-regulate a significant cluster of genes, indicating an interplay between the 2 proteins in regulating cellular functions. We found that among the EWS-down-regulated genes are a subset of neuronal genes that contain binding sites for the RE1-silencing transcription factor (REST or neuron-restrictive silencer factor [NRSF]), neuron-restrictive silencer element (NRSE), suggesting a cooperative interaction between REST and EWS in gene regulation. Co-immunoprecipitation analysis demonstrated that EWS interacts directly with REST. Genome-wide binding analysis showed that EWS binds chromatin at or near NRSE. Furthermore, functional studies revealed that both EWS and REST inhibit neuronal phenotype development and oncogenic transformation in Ewing sarcoma cells. Our data implicate an important role of EWS in the development of Ewing sarcoma phenotype and highlight a potential value in modulating EWS function in the treatment of Ewing sarcoma and other EWS translocation-based cancers.
Insights
Wild-type EWSR1 (EWS) and the EWS/FLI oncoprotein co-regulate genes in Ewing sarcoma. EWS interacts with REST to suppress neuronal development and oncogenic transformation, offering potential therapeutic targets.
Area of Science:
- Oncology
- Molecular Biology
- Gene Regulation
Background:
- EWSR1 gene translocations create oncoproteins driving cancers like Ewing sarcoma.
- The oncogenic EWS/FLI fusion protein is key in Ewing sarcoma, but wild-type EWS function is unclear.
Purpose of the Study:
- Investigate the role of wild-type EWSR1 (EWS) in Ewing sarcoma pathogenesis.
- Identify EWS-regulated genes and cellular processes.
- Explore the interplay between EWS and EWS/FLI.
Main Methods:
- RNA interference and RNA sequencing to identify EWS-regulated genes.
- Functional annotation and co-immunoprecipitation analyses.
- Genome-wide chromatin binding analysis.
Main Results:
- EWS and EWS/FLI co-regulate a subset of genes.
- EWS interacts with REST (RE1-silencing transcription factor) and binds chromatin near NRSE.
- Both EWS and REST inhibit neuronal phenotype and oncogenic transformation in Ewing sarcoma cells.
Conclusions:
- Wild-type EWS plays a significant role in Ewing sarcoma phenotype development.
- EWS and REST cooperate in gene regulation.
- Modulating EWS function may offer a therapeutic strategy for Ewing sarcoma and related cancers.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal
Mitogens and the Cell Cycle
Abnormal Proliferation
Replicative Cell Senescence
Induced Pluripotent Stem Cells
Somatic cells are...

